Effects of Rhizoma Paridis Pharmacologic Serum on Proliferation and Apoptosis of Human Gastric Carcinoma Cell Line SGC7901 in Vitro

ZHANG Ke,MOU Han-zhou,FENG Jian-guo,GU Lin-hui,MA Sheng-lin
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2011.12.001
2011-01-01
Abstract:OBJECTIVE: To explore the effect of rhizoma paridis pharmacologic serum on proliferation and apoptosis of human gastric carcinoma cell line SGC7901 in vitro.METHODS: SGC7901 cell line was cultured with different concentration of rhizoma paridis pharmacologic serum,and its proliferation and apoptosis was detected by MMT and flowcytometric,repectively.RESULTS: The survival of SGC7901 cells was decreased after 24,48,72 h after culturing with different concentration of rhizoma paridis pharmacologic serum,and it was correlated with the culturing time and contents.After 24 h culturing with rhizoma paridis pharmacologic serum,the cells in S stage were increased;the apoptosis rate of the 3 groups was(6.67±1.34)%,(13.12±1.34)%,(20.43±1.24)%,and 5-FU add Rhizoma Paridis was(22.61±3.01)% as compared with control group(4.35±1.09)% and fluorouracil group(19.22±1.66)%,respectively,with a significant difference(P0.01).CONCLUSION: Rhizoma paridis pharmacologic serum can inhibit the growth of SGC7901,and may induce the apoptosis of SGC7901 cells.
What problem does this paper attempt to address?